Novartis Earnings Preview: Can New Medicines Offset Generic Pressure and Growing U.S. Pricing Risks?

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 2 hours ago

Google makes a fresh bet on nuclear power as the AI energy crunch intensifies

Constellation’s stock is rising sharply following a deal that equates to as much power as would be supplied by a new nuclear reactor.

MarketWatch

marketsabout 2 hours ago

America’s favorite index is misleading investors about the state of the stock market

For decades, the S&P 500 has been the preferred benchmark for monitoring the performance of the U.S. stock market. But these days, it is behaving less like a barometer of broad market health and more like a funhouse mirror.

MarketWatch

marketsabout 3 hours ago

Wall Street is hyping AI. This fund manager is betting instead on fires, HVAC and Berkshire Hathaway.

The co-portfolio manager at Heartland Advisors urges investors to shut out Wall Street’s hype on AI and look for companies that can use its technology as costs come down.

MarketWatch